Harvard Bioscience (HBIO) Current Assets (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Current Assets of $47.5 million for Q1 2026, up 5.74% year-over-year from $44.9 million in Q1 2025, and down 1.55% quarter-over-quarter from $48.2 million in Q4 2025.
Harvard Bioscience (HBIO) Current Assets (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Current Assets for 17 consecutive years, with $47.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets rose 5.74% year-over-year to $47.5 million; the TTM figure through Mar 2026 stood at $47.5 million (up 5.74% YoY), while the FY2025 annual figure was $48.2 million, up 6.89% from the prior year.
- Current Assets retreated to $47.5 million in Q1 2026 per HBIO's latest filing, from $48.2 million in the prior quarter.
- Across five years, Current Assets topped out at $59.4 million in Q1 2022 and bottomed at $43.8 million in Q3 2025.
- Historically, Current Assets has averaged $49.4 million across 5 years, with a median of $48.2 million in 2025.
- On a YoY basis, Current Assets climbed as much as 20.77% in 2022 and fell as far as 16.98% in 2022.
- Harvard Bioscience's Current Assets stood at $51.1 million in 2022, then retreated by 4.08% to $49.0 million in 2023, then fell by 8.0% to $45.1 million in 2024, then gained by 6.89% to $48.2 million in 2025, then dropped by 1.55% to $47.5 million in 2026.
- Business Quant data shows HBIO's Current Assets at $47.5 million in Q1 2026, $48.2 million in Q4 2025, and $43.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 9.54 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 8.14 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 6.62 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 4.32 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 11.74 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 1.81 Bn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 3.74 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 2.30 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 6.99 Bn |
| 10 | Harvard Bioscience | 34.12 Mn | 27.61 Mn | 12.63 Mn | 46.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 46.46 Mn |
| Mar 31, 2026 | 47.48 Mn |
| Dec 31, 2025 | 48.23 Mn |
| Sep 30, 2025 | 43.81 Mn |
| Jun 30, 2025 | 44.97 Mn |
| Mar 31, 2025 | 44.90 Mn |
| Dec 31, 2024 | 45.12 Mn |
| Sep 30, 2024 | 46.79 Mn |
| Jun 30, 2024 | 46.43 Mn |
| Mar 31, 2024 | 48.15 Mn |
| Dec 31, 2023 | 49.04 Mn |
| Sep 30, 2023 | 50.49 Mn |
| Jun 30, 2023 | 52.62 Mn |
| Mar 31, 2023 | 52.45 Mn |
| Dec 31, 2022 | 51.12 Mn |
| Sep 30, 2022 | 51.82 Mn |
| Jun 30, 2022 | 56.50 Mn |
| Mar 31, 2022 | 59.45 Mn |
| Dec 31, 2021 | 61.58 Mn |
| Sep 30, 2021 | 55.69 Mn |